SynsorBio is a Chinese leading CRISPR diagnostics company, combining the power of our proprietary CRISPR-based detection technology and the integration of microfluidics and synthetic biology, to apply in the field of Point-of-care testing (POCT). Since founded in 2020, SynsorBio has been dedicated to R&D, manufacturing, and sales of high quality diagnostic reagents and instruments....